Awakn Life Sciences (OTC:AWKNF), a clinical-stage biotechnology company specializing in the development of ketamine-assisted treatments for addiction, has entered into a global licensing agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback